BIRAC SEED Fund Checklist 2026: Mandatory Documents, Fees & Eligibility

Introduction to BIRAC SEED Fund

Early-stage biotechnology and healthcare startups often face a severe financial gap when moving from laboratory proof-of-concept to commercial validation. Traditional venture capital firms and commercial banks frequently hesitate to fund high-risk life science research and development due to long gestation periods and complex regulatory pathways. To address this hurdle, the Biotechnology Industry Research Assistance Council (BIRAC)—operating under the Department of Biotechnology (DBT), Government of India—administers the BIRAC SEED Fund (Sustainable Entrepreneurship and Enterprise Development Fund).

Designed to deliver institutional investment directly to high-potential innovators, this scheme provides up to ₹1 Crore in seed capital through premier bio-incubators such as C-CAMP Bengaluru, Venture Center Pune, IKP Knowledge Park Hyderabad, and FITT IIT Delhi. Whether you are building breakthrough diagnostics, novel biopharmaceuticals, or advanced medtech devices, navigating the eligibility parameters, compiling the mandatory documentation checklist, and meeting compliance rules are vital steps toward securing this non-dilutive and patient capital.

For entrepreneurs ready to accelerate their life science venture, explore detailed insights and initiate your journey via our BIRAC SEED Fund scheme portal.

Scheme Overview & Objective

The core mission of the BIRAC SEED Fund is to bridge the early-stage financing gap for biotech entrepreneurs by offering flexible financial support. Rather than rigid debt schedules, the capital is structured thoughtfully as equity, optionally convertible preference shares (OCPS), or low-interest soft loans, ensuring founder-friendly institutional backing.

Funded enterprises utilize this capital for targeted operational milestones, which include:

• Executing pilot scale-up manufacturing batches for clinical evaluation.
• Conducting regulatory pre-clinical and clinical validation studies.
• Filing international Patent Cooperation Treaty (PCT) applications to protect intellectual property.
• Obtaining mandatory CDSCO approvals and ISO medical device certifications.

Administered via accredited bio-incubators, the scheme not only infuses financial capital but also integrates startups into a world-class scientific ecosystem equipped with advanced instrumentation and technical mentorship.

Eligibility Criteria & Scope

Before initiating your application for the BIRAC SEED Fund eligibility documents checklist, founders must ensure their enterprise satisfies every mandatory criterion established by DBT and BIRAC. The framework is strictly curated for early-stage life science innovators meeting the following parameters:

• Incorporation Status: Must be a DPIIT-recognized startup incorporated as a Private Limited Company in India with an existence of under 5 years.
• Incubation Requirement: The entity must be physically or virtually incubated at an officially approved BIRAC Bio-Incubator.
• Shareholding Pattern: At least 51% of the total equity shareholding must be owned by Indian resident citizens.
• Technological Readiness: Must have developed a validated laboratory proof-of-concept or prototype in biotechnology, medtech, or healthcare.
• Strategic Roadmap: Must present a clear, actionable roadmap covering regulatory pathways, preclinical validation, and commercial launch.
• Founder Competence: Founders must possess demonstrable technical domain competence in life sciences, bioengineering, or clinical medicine.

Key Financial & Growth Benefits

Securing support through the BIRAC SEED Fund unlocks transformative advantages for early-stage life science companies. Understanding these benefits helps founders align their commercial strategies with national incentives:

• Substantial Seed Capital: Receive financial infusion up to ₹1 Crore structured flexibly as equity, soft loans, or convertible debt.
• Premier Bio-Incubator Access: Gain direct entry into world-class BSL-2/3 laboratories, flow cytometry facilities, NMR units, and cleanrooms.
• Regulatory & Clinical Guidance: Receive expert mentorship on navigating complex CDSCO clinical trial approvals and ethics committee filings.
• Patient Capital Terms: Benefit from longer gestation horizons and valuation structures tailored specifically for life science research cycles.
• Co-Investment Multiplication: Leverage institutional catalytic capital to unlock follow-on Series A rounds from leading healthcare VC funds.
• Global Bio-Partnering: Access sponsored representation at major international conventions such as BIO USA, Bio-Europe, and MedTech Innovator.

Application Procedure & Documents Checklist

A meticulous approach to the application process prevents delays and ensures compliance with institutional standards. The following BIRAC SEED Fund document checklist outlines all mandatory items required during submission:

• Certificate of Incorporation: Official corporate registration documents, including the Memorandum of Association (MoA), Articles of Association (AoA), and Company PAN Card.
• Startup Recognition: DPIIT Startup Recognition Certificate accompanied by a valid Bio-Incubator Incubation Agreement.
• Comprehensive Business Plan: Detailed operational plan outlining the clinical and regulatory roadmap, alongside realistic financial projections.
• Financial Breakdown: Itemized budget breakdown showing exact utilization projections for the requested seed support up to ₹1 Crore.
• Financial Statements: Audited balance sheets or a Chartered Accountant (CA) Net Worth Certificate.
• Founder KYC: Valid Aadhaar and PAN cards for all founding directors and key promoters.
• Banking Details: Company bank account statements and a cancelled cheque for institutional disbursement tracking.

To begin reviewing your application strategy and verify your enterprise readiness, visit our BIRAC SEED Fund guide.

Step-by-Step Application Workflow

Applicants must follow a structured workflow coordinated through their host bio-incubator:

1. Incubation Admission: Secure physical or virtual incubation status at an authorized BIRAC Bio-Incubator (e.g., C-CAMP, Venture Center, IKP, FITT).
2. Proposal Drafting: Prepare the technical dossier, regulatory roadmap, and financial budget in alignment with BIRAC guidelines.
3. Internal Screening: Submit the proposal to the host incubator for initial technical evaluation and feasibility review.
4. Ancillary Pitching: Present the innovation before the Apex Selection Committee comprising domain experts, scientists, and financial analysts.
5. Due Diligence & Disbursement: Upon final approval, execute legal agreements regarding equity or soft loan structures and receive tranche-wise funding disbursement.

Official FAQs

1. What is the maximum funding amount available under the BIRAC SEED Fund?

Eligible startups can receive seed funding of up to ₹1 Crore, structured as equity, optionally convertible preference shares (OCPS), or low-interest soft loans.

2. Who is eligible to apply for this scheme?

DPIIT-recognized Indian Private Limited startups under 5 years of age that are incubated at a BIRAC-approved bio-incubator, possess at least 51% Indian shareholding, and have a validated proof-of-concept in biotech or medtech are eligible.

3. Can an unincubated startup apply directly to BIRAC?

No. Incubation at an officially accredited BIRAC Bio-Incubator is a mandatory prerequisite for submitting an application under this scheme.

4. What kind of projects are prioritized for funding?

Projects focusing on biopharmaceuticals, medical devices, diagnostics, agribio, and industrial biotechnology that demonstrate a clear regulatory pathway and commercial validation roadmap are given top priority.

5. How can I start my application process today?

Review the comprehensive guidelines and start your submission workflow by visiting our dedicated BIRAC SEED Fund portal.